Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Effects of Radiation02:59

Biological Effects of Radiation

19.9K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
19.9K
Radiation: Applications01:17

Radiation: Applications

2.1K
The average temperature of Earth is the subject of much current discussion. Earth is in radiative contact with both the Sun and dark space; it receives almost all its energy from the radiation of the Sun and reflects some of it into outer space. Dark space is very cold, about 3 K, so Earth radiates energy into it. For instance, heat transfer occurs from soil and grasses, the rate of which can be so rapid that frost can occur on clear summer evenings, even in warm latitudes.
The average...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply: A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECT.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

An international study of factors affecting variability of dosimetry calculations, part 5: impact of segmentation methods.

EJNMMI physics·2026
Same author

Assessing PSMA Receptor Availability Using 68Ga-PSMA-11 PET/CT Following 177Lu-PSMA-617 Therapy Administration.

Clinical nuclear medicine·2026
Same author

Comparison of imaging-based bone marrow dosimetry methodologies and their dose-effect relationships in [<sup>177</sup>Lu]Lu-PSMA-617 RLT including a novel method with active marrow localization.

EJNMMI physics·2025
Same author

Posology for 177Lu-DOTATATE Therapy in Neuroendocrine Tumor: Effectiveness of Dose Reduction and Cycle Delay for Improving Therapy Tolerability.

Clinical nuclear medicine·2025
Same author

ADVERSARIAL SYNTHESIS LEARNING ENABLES SEGMENTATION WITHOUT TARGET MODALITY GROUND TRUTH.

Proceedings. IEEE International Symposium on Biomedical Imaging·2025
Same journal

Review of Glypican-3-Targeted Imaging Agents for Hepatocellular Carcinoma.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Clinical Laboratory Evaluation of the Biodistribution of a Radiolabeled Antimicrobial Peptide for Precision Radiopharmaceutical-Guided Radionuclide Therapy in Severe Pneumonia Among Immunocompromised Patients with Cancer.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Single-Cell Transcriptomics in Triple-Negative Breast Cancer: Implications for Radionuclide Therapy in Precision Oncology.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Curved Vertebroplasty System Combined with Targeted Radionuclide Therapy for Tumor-Related Pathological Vertebral Fractures.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Development of a Freeze-Dried Bevacizumab Kit for <sup>99m</sup>Tc Radiolabeling and Preclinical Evaluation <i>In Vitro</i> and in Normal Mice.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Radionuclide-Based Theranostic Mapping for Spatially Optimized Treatment Planning in Cervical Carcinoma.

Cancer biotherapy & radiopharmaceuticals·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.6K

VIDA: a voxel-based dosimetry method for targeted radionuclide therapy using Geant4.

Susan D Kost1, Yuni K Dewaraja, Richard G Abramson

  • 11 Department of Physics and Astronomy, Vanderbilt University , Nashville, Tennessee.

Cancer Biotherapy & Radiopharmaceuticals
|January 17, 2015
PubMed
Summary
This summary is machine-generated.

The Voxel-Based Internal Dosimetry Application (VIDA) accurately calculates patient-specific radiation doses for radionuclide therapy. Validation studies show high agreement with established methods, ensuring reliable dosimetry for targeted treatments.

Keywords:
3D dosimetryMonte CarloSPECT/CTpatient-specific dosimetryradioimmunotherapy

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.4K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

10.2K

Related Experiment Videos

Last Updated: Apr 18, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.6K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.4K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

10.2K

Area of Science:

  • Medical Physics
  • Nuclear Medicine
  • Computational Biology

Background:

  • Accurate patient-specific dosimetry is crucial for effective targeted radionuclide therapy.
  • Monte Carlo simulations offer a powerful tool for detailed radiation transport modeling.
  • Existing dosimetry methods require validation for novel applications.

Purpose of the Study:

  • To introduce and validate the Voxel-Based Internal Dosimetry Application (VIDA) for patient-specific dosimetry in radionuclide therapy.
  • To assess the accuracy of VIDA by comparing its results with established dosimetry data and codes.
  • To demonstrate the clinical utility of VIDA in estimating radiation doses for cancer patients.

Main Methods:

  • Development of the VIDA software using Geant4 toolkit for Monte Carlo simulations.
  • Generation of voxel-level dose rate maps from patient-specific anatomical and physiological data.
  • Validation against OLINDA/EXM self-dose factors and RADAR reference phantom data for common radionuclides ((131)I, (90)Y, (111)In, (177)Lu).
  • Comparison of VIDA's dose estimates with another dosimetry code for (131)I radioimmunotherapy in non-Hodgkin Lymphoma patients.

Main Results:

  • VIDA demonstrated agreement within 5% for self-dose factors compared to reference data.
  • Cross-organ dose factors showed agreement within 9% with reference data.
  • Mean absorbed tumor doses in patients showed a relative difference of 12% or less compared to an independent dosimetry code, accounting for tumor regression.

Conclusions:

  • VIDA provides accurate and reliable patient-specific dosimetry for targeted radionuclide therapy.
  • The validation studies confirm VIDA's capability to generate precise voxel-level dose maps.
  • VIDA is a promising tool for optimizing radionuclide therapy treatment planning and delivery.